{"id":23000035,"date":"2025-10-27T11:48:06","date_gmt":"2025-10-27T10:48:06","guid":{"rendered":"https:\/\/www.karoip.com\/unkategorisiert\/2025\/10\/ipo-of-cf-pharmtech\/"},"modified":"2025-10-30T11:31:29","modified_gmt":"2025-10-30T10:31:29","slug":"ipo-of-cf-pharmtech","status":"publish","type":"post","link":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/","title":{"rendered":"IPO of CF PharmTech"},"content":{"rendered":"<h1>Successful IPO for CF PharmTech<\/h1>\n<h2>karo IP supports IPO with IP expertise<\/h2>\n<p>On October 8, 2025, one of our clients, the pharmaceutical company CF PharmTech (headquartered in Suzhou, China), successfully completed its listing on the Hong Kong Stock Exchange (HKSE).<\/p>\n<p>Our client is a fully integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of drugs and devices for the treatment of respiratory diseases. The company&#8217;s core product is <g id=\"gid_0\">Budesonide Suspension (CF017)<\/g>, a drug for the treatment of asthma and COPD that is included in <g id=\"gid_1\">China&#8217;s<\/g> volume-based procurement program. In addition, the company has other products and a pipeline of innovative therapies, including RNAi therapies and small molecule drugs.  <\/p>\n<p>The IPO was heavily oversubscribed and the share price rose significantly on the first day of trading, reflecting strong investor interest in the company&#8217;s focus on the treatment of respiratory diseases and its path to profitability.<\/p>\n<p>We are very pleased to have been asked to support our client&#8217;s IPO with various searches, valuations and opinions on patents, utility models and trademarks in the European territories, thus contributing to the successful IPO of CF PharmTech and its further successful path on the European market.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Successful IPO for CF PharmTech karo IP supports IPO with IP expertise On October 8, 2025, one of our clients, the pharmaceutical company CF PharmTech (headquartered in Suzhou, China), successfully completed its listing on the Hong Kong Stock Exchange (HKSE). Our client is a fully integrated pharmaceutical company focused on the research, development, manufacturing, and [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":23000026,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[135,153],"tags":[226,224,225,227],"class_list":["post-23000035","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-sonstiges-en","tag-cf-pharmtech","tag-ipo","tag-pharmaceuticals","tag-suzhou"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IPO of CF PharmTech | karo IP accompanies IPO<\/title>\n<meta name=\"description\" content=\"Successful IPO of CF PharmTech with the core product Budesonide Suspension (CF017) on the Hong Kong Stock Exchange (HKSE).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IPO of CF PharmTech | karo IP accompanies IPO\" \/>\n<meta property=\"og:description\" content=\"Successful IPO of CF PharmTech with the core product Budesonide Suspension (CF017) on the Hong Kong Stock Exchange (HKSE).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/\" \/>\n<meta property=\"og:site_name\" content=\"karo IP | Patentanwaltskanzlei\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-27T10:48:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-30T10:31:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.karoip.com\/wp-content\/uploads\/2025\/10\/Boersengang-CF-PharmTech.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Matthias R\u00f6\u00dfler\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Matthias R\u00f6\u00dfler\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/blog-en\\\/sonstiges-en\\\/2025\\\/10\\\/ipo-of-cf-pharmtech\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/blog-en\\\/sonstiges-en\\\/2025\\\/10\\\/ipo-of-cf-pharmtech\\\/\"},\"author\":{\"name\":\"Matthias R\u00f6\u00dfler\",\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/#\\\/schema\\\/person\\\/9624951de62007cce98c66acf2775be4\"},\"headline\":\"IPO of CF PharmTech\",\"datePublished\":\"2025-10-27T10:48:06+00:00\",\"dateModified\":\"2025-10-30T10:31:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/blog-en\\\/sonstiges-en\\\/2025\\\/10\\\/ipo-of-cf-pharmtech\\\/\"},\"wordCount\":200,\"image\":{\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/blog-en\\\/sonstiges-en\\\/2025\\\/10\\\/ipo-of-cf-pharmtech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.karoip.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Boersengang-CF-PharmTech.webp\",\"keywords\":[\"CF PharmTech\",\"IPO\",\"Pharmaceuticals\",\"Suzhou\"],\"articleSection\":[\"News\",\"Other\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/blog-en\\\/sonstiges-en\\\/2025\\\/10\\\/ipo-of-cf-pharmtech\\\/\",\"url\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/blog-en\\\/sonstiges-en\\\/2025\\\/10\\\/ipo-of-cf-pharmtech\\\/\",\"name\":\"IPO of CF PharmTech | karo IP accompanies IPO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/blog-en\\\/sonstiges-en\\\/2025\\\/10\\\/ipo-of-cf-pharmtech\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/blog-en\\\/sonstiges-en\\\/2025\\\/10\\\/ipo-of-cf-pharmtech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.karoip.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Boersengang-CF-PharmTech.webp\",\"datePublished\":\"2025-10-27T10:48:06+00:00\",\"dateModified\":\"2025-10-30T10:31:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/#\\\/schema\\\/person\\\/9624951de62007cce98c66acf2775be4\"},\"description\":\"Successful IPO of CF PharmTech with the core product Budesonide Suspension (CF017) on the Hong Kong Stock Exchange (HKSE).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/blog-en\\\/sonstiges-en\\\/2025\\\/10\\\/ipo-of-cf-pharmtech\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.karoip.com\\\/en\\\/blog-en\\\/sonstiges-en\\\/2025\\\/10\\\/ipo-of-cf-pharmtech\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/blog-en\\\/sonstiges-en\\\/2025\\\/10\\\/ipo-of-cf-pharmtech\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.karoip.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Boersengang-CF-PharmTech.webp\",\"contentUrl\":\"https:\\\/\\\/www.karoip.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Boersengang-CF-PharmTech.webp\",\"width\":2048,\"height\":960,\"caption\":\"B\u00f6rsengang von CF PharmTech\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/blog-en\\\/sonstiges-en\\\/2025\\\/10\\\/ipo-of-cf-pharmtech\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IPO of CF PharmTech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/\",\"name\":\"karo IP | Patentanwaltskanzlei\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.karoip.com\\\/en\\\/#\\\/schema\\\/person\\\/9624951de62007cce98c66acf2775be4\",\"name\":\"Matthias R\u00f6\u00dfler\",\"sameAs\":[\"http:\\\/\\\/karoip.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IPO of CF PharmTech | karo IP accompanies IPO","description":"Successful IPO of CF PharmTech with the core product Budesonide Suspension (CF017) on the Hong Kong Stock Exchange (HKSE).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/","og_locale":"en_US","og_type":"article","og_title":"IPO of CF PharmTech | karo IP accompanies IPO","og_description":"Successful IPO of CF PharmTech with the core product Budesonide Suspension (CF017) on the Hong Kong Stock Exchange (HKSE).","og_url":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/","og_site_name":"karo IP | Patentanwaltskanzlei","article_published_time":"2025-10-27T10:48:06+00:00","article_modified_time":"2025-10-30T10:31:29+00:00","og_image":[{"width":2048,"height":960,"url":"https:\/\/www.karoip.com\/wp-content\/uploads\/2025\/10\/Boersengang-CF-PharmTech.webp","type":"image\/webp"}],"author":"Matthias R\u00f6\u00dfler","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Matthias R\u00f6\u00dfler","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/#article","isPartOf":{"@id":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/"},"author":{"name":"Matthias R\u00f6\u00dfler","@id":"https:\/\/www.karoip.com\/en\/#\/schema\/person\/9624951de62007cce98c66acf2775be4"},"headline":"IPO of CF PharmTech","datePublished":"2025-10-27T10:48:06+00:00","dateModified":"2025-10-30T10:31:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/"},"wordCount":200,"image":{"@id":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/#primaryimage"},"thumbnailUrl":"https:\/\/www.karoip.com\/wp-content\/uploads\/2025\/10\/Boersengang-CF-PharmTech.webp","keywords":["CF PharmTech","IPO","Pharmaceuticals","Suzhou"],"articleSection":["News","Other"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/","url":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/","name":"IPO of CF PharmTech | karo IP accompanies IPO","isPartOf":{"@id":"https:\/\/www.karoip.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/#primaryimage"},"image":{"@id":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/#primaryimage"},"thumbnailUrl":"https:\/\/www.karoip.com\/wp-content\/uploads\/2025\/10\/Boersengang-CF-PharmTech.webp","datePublished":"2025-10-27T10:48:06+00:00","dateModified":"2025-10-30T10:31:29+00:00","author":{"@id":"https:\/\/www.karoip.com\/en\/#\/schema\/person\/9624951de62007cce98c66acf2775be4"},"description":"Successful IPO of CF PharmTech with the core product Budesonide Suspension (CF017) on the Hong Kong Stock Exchange (HKSE).","breadcrumb":{"@id":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/#primaryimage","url":"https:\/\/www.karoip.com\/wp-content\/uploads\/2025\/10\/Boersengang-CF-PharmTech.webp","contentUrl":"https:\/\/www.karoip.com\/wp-content\/uploads\/2025\/10\/Boersengang-CF-PharmTech.webp","width":2048,"height":960,"caption":"B\u00f6rsengang von CF PharmTech"},{"@type":"BreadcrumbList","@id":"https:\/\/www.karoip.com\/en\/blog-en\/sonstiges-en\/2025\/10\/ipo-of-cf-pharmtech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.karoip.com\/en\/"},{"@type":"ListItem","position":2,"name":"IPO of CF PharmTech"}]},{"@type":"WebSite","@id":"https:\/\/www.karoip.com\/en\/#website","url":"https:\/\/www.karoip.com\/en\/","name":"karo IP | Patentanwaltskanzlei","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.karoip.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.karoip.com\/en\/#\/schema\/person\/9624951de62007cce98c66acf2775be4","name":"Matthias R\u00f6\u00dfler","sameAs":["http:\/\/karoip.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.karoip.com\/en\/wp-json\/wp\/v2\/posts\/23000035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.karoip.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.karoip.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.karoip.com\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.karoip.com\/en\/wp-json\/wp\/v2\/comments?post=23000035"}],"version-history":[{"count":1,"href":"https:\/\/www.karoip.com\/en\/wp-json\/wp\/v2\/posts\/23000035\/revisions"}],"predecessor-version":[{"id":23000046,"href":"https:\/\/www.karoip.com\/en\/wp-json\/wp\/v2\/posts\/23000035\/revisions\/23000046"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.karoip.com\/en\/wp-json\/wp\/v2\/media\/23000026"}],"wp:attachment":[{"href":"https:\/\/www.karoip.com\/en\/wp-json\/wp\/v2\/media?parent=23000035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.karoip.com\/en\/wp-json\/wp\/v2\/categories?post=23000035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.karoip.com\/en\/wp-json\/wp\/v2\/tags?post=23000035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}